IL-15/IL-15Ra Synergies with IL-12 to Induce Functional CD8 T Cells and NK Cells During Chronic SHIV Infection

Area of Science:

• Immunology
• Virology
• Cancer Research

Background:

• Cytokines are crucial for immune regulation and communication.
• Interleukin-15 (IL-15) and Interleukin-12 (IL-12) have individual therapeutic potential.
• The combined effect of IL-15/IL-15Rα and IL-12 in immunotherapy is unexplored.

Purpose of the Study:

• To investigate the combined therapeutic potential of IL-15/IL-15Rα and IL-12.
• To evaluate the enhancement of Natural Killer (NK) cells and CD8 T cells.
• To compare combination therapy with single cytokine treatments.

Main Methods:

• In vitro cytokine treatment of immune cells from macaques.
• Analysis of CD8 T cell and NK cell expansion and function.
• Assessment of CCR5 expression on CD4 T cells.

Main Results:

• IL-15/IL-15Rα and combination IL-15/IL-15Rα plus IL-12 expanded functional CD8 T cells and NK cells.
• The combination therapy significantly reduced CCR5 expression on CD4 T cells.
• Enhanced immune cell activity was observed in both uninfected and simian/human immunodeficiency virus-infected macaques.

Conclusions:

• Combined IL-15/IL-15Rα plus IL-12 treatment enhances immune cell potency and quality.
• This cytokine combination may limit viral spread by reducing target cells.
• The findings support the use of combined IL-15/IL-15Rα and IL-12 for chronic viral infections and cancer immunotherapy.